Clinical Trial Update: Study to Determine the Effect of Efavirenz on the ECG QTcF Interval in Healthy Subjects [Phase 1]

View source ↗

Summary

Phase 1 study evaluating whether efavirenz affects the QTcF interval in healthy subjects. The trial status is completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Aids

Drugs mentioned

• EFAVIRENZ (efavirenz)

Snippet

Sponsor: Bristol-Myers Squibb | Conditions: HIV/AIDS | Phase 1 | Status: COMPLETED